NIH launched clinical trials network to test COVID-19 vaccines and other prevention tools
On Jul. 8, 2020, the National Institute of Allergy and Infectious Diseases announced it had established a new…
From lung scarring to heart damage, COVID-19 may leave lingering marks
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
Biotechnology | COVID-19 | Disease | Life Science News | Therapeutics | WHO
Access to HIV medicines severely impacted by COVID-19 as AIDS response stalled
On Jul. 8, 2020, seventy-three countries warned that they were at risk of stock-outs of antiretroviral (ARV) medicines…
Kaiser Permanente Washington announced COVID-19 vaccine trial registry opened for volunteers
On Jul. 8, 2020, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that it had created a registry…
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers formed collaboration to develop Emergent’s COVID-19 hyperimmune globulin product
On Jul. 8, 2020, the Mount Sinai Health System, Emergent BioSolutions and ImmunoTek Bio Centers announced a collaboration…
Gilead Sciences reported survey findings on PrEP access and utilization in the US during COVID-19 shelter-in-place orders
On Jul. 8, 2020, Gilead Sciences announced data evaluating the impact of COVID-19 shelter-in-place orders (SIPOs) and PrEP…
Kleo Pharmaceuticals announced $5 million grant to advance development of COVID-19 hyperimmune globulin mimic as therapeutic for infected patients
On Jul. 8, 2020, Kleo Pharmaceuticals announced that it had received a $5 million grant from the Bill…
NanoViricides reported safety and tolerability of anti-Coronavirus drug candidates observed in animal model
On Jul. 8, 2020, NanoViricides announced that excellent safety and tolerability of the drug candidates it is developing…
Moderna completed enrollment of phase 2 study of its mRNA vaccine against COVID-19 (mRNA-1273)
On Jul. 8, 2020, Moderna announced that it had completed enrollment for both cohorts of the Phase 2…
Constant Therapeutics’ TXA127 tested in multiple clinical trials for COVID-19 patients
On Jul. 8, 2020, Constant Therapeutics reported that its peptide drug TXA127 was tested in a series of…
Fred Hutch joined international COVID-19 vaccine effort
On Jul. 8, 2020, the Fred Hutchinson Cancer Research Center was named the coordinating center for vaccine clinical…
Texas A&M, MD Anderson Scientists tested inhaled therapeutic to protect against COVID-19
On Jul. 8, 2020, scientists from Texas A&M University, biopharmaceutical company Pulmotect and MD Anderson Cancer Center announced…
National UK study investigated long-term health impacts of COVID-19
On Jul. 7, 2020, a major UK research study – PHOSP-COVID, will investigate the long-term health impacts of…
Oxford COVID-19 study reported face masks work, call for immediate adoption
On Jul. 7, 2020, Oxfordﾒs Leverhulme Centre for Demographic Science reported that cloth face coverings, even homemade masks…
GSK and Medicago announced collaboration to develop a novel adjuvanted COVID-19 candidate vaccine
On Jul. 7, 2020, GlaxoSmithKline and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine…
Cerus reported successful inactivation of SARS-CoV-2 with the INTERCEPT Blood System for Plasma
On Jul. 7, 2020, Cerus announced study results that demonstrated the INTERCEPT Blood System inactivates SARS-CoV-2, the causative…
In vitro testing of Innovation Pharmasﾒ Brilacidin for COVID-19 showed consistent anti-SARS-CoV-2 efficacy
On Jul. 7, 2020, Innovation Pharma reported the latest developments related to research into Brilacidin as a potential…
Novavax announced $1.6 billion funding from Operation Warp Speed
On Jul. 7, 2020, Novavax announced that it had been selected to participate in Operation Warp Speed, a…
LabCorp lanuched first digital COVID-19 service that improves the doctor and patient experience
On Jul. 7, 2020, LabCorpﾮ launched the LabCorp At Home COVID-19 Test Collection Service, the first seamless digital…
Regeneron announced manufacturing and supply agreement for BARDA and U.S. DoD for REGN-COV2 anti-viral antibody cocktail
On Jul. 7, 2020, Regeneron announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and…
Corvus Pharmaceuticals initiated clinical trial of novel immunotherapy for patients with COVID-19
On Jul. 7, 2020, Corvus Pharmaceuticals announced that it has initiated a Phase 1 study to investigate a…
Tonix Pharma announced plans for Massachusetts R&D facility to accelerate clinical development of vaccines and protein-based therapeutics
On Jul. 7, 2020, Tonix Pharmaceuticals announced its intent to purchase an approximately 40,000 square foot facility in…
The FDA issued an emergency use authorization for the third diagnostic test for detection and differentiation of the viruses that cause flu and COVID-19
On Jul. 6, 2020, the FDA issued an emergency use authorization (EUA) for the third diagnostic test for…
Ignoring airborne COVID spread risky
On Jul. 6, 2020, the lack of universal recognition that COVID-19 is transmitted via airborne particles, along with…
Sinovac COVID-19 vaccine collaboration with Butantan received approval from Brazilian regulator for phase III trial
On Jul. 6, 2020, Sinovac Biotech announced that on Jul. 3, 2020, the Brazilian National Regulatory Agency, Anvisa,…
Immune Regulation partnered with DynPort Vaccine to advance drug product for COVID-19 into clinical trials
On Jul. 9, 2020, Altimmune announced that it had entered into a teaming agreement with DynPort Vaccine Company…
AIM ImmunoTech signed material transfer and research agreement with Japan’s National Institute of Infectious Diseases and Shionogi & Co to test Ampligen as potential vaccine adjuvant for COVID-19
On Jul. 6, 2020, AIM ImmunoTech announced that it had signed a material transfer and research agreement with…
BD launched portable, rapid point-of-care antigen test to detect SARS-CoV-2 in 15 minutes, expanding access to COVID-19 testing
On Jul. 6, 2020, BD (Becton, Dickinson) announced the U.S. Food and Drug Administration (FDA) had granted Emergency…
Regeneron announced start of REGN-COV2 phase 3 COVID-19 prevention trial in collaboration with National Institute of Allergy and Infectious Diseases
On Jul. 6, 2020, Regeneron announced initiation of late-stage clinical trials evaluating REGN-COV2, Regeneron’s investigational double antibody cocktail…
Mylan secured regulatory approval for remdesivir lyophilized powder for injection 100 mg/vial in India for restricted emergency use in COVID-19 patients
On Jul. 6, 2020, Mylan announced that the Drug Controller General of India (DCGI) has approved its remdesivir…